Trial · NCT03068455
Results by group34
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 34
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Recurrence-free Survival (RFS) - All Randomized Participants | Arm A: Nivo + Ipi | NA | 95% Confidence Interval NA to NA | Months | |
| Recurrence-free Survival (RFS) - All Randomized Participants | Arm B: Nivo | NA | 95% Confidence Interval NA to NA | Months | |
| Recurrence-free Survival (RFS) - All Randomized Participants With PD-L1 Expression Level < 1% | Arm A: Nivo + Ipi | 33.15 | 95% Confidence Interval 22.21 to NA | Months | |
| Recurrence-free Survival (RFS) - All Randomized Participants With PD-L1 Expression Level < 1% | Arm B: Nivo | 27.63 | 95% Confidence Interval 19.81 to NA | Months | |
| Overall Survival (OS) - All Randomized Participants | Arm A: Nivo + Ipi | NA | 95% Confidence Interval NA to NA | Months | |
| Overall Survival (OS) - All Randomized Participants | Arm B: Nivo | NA | 95% Confidence Interval NA to NA | Months | |
| Overall Survival (OS) - All Randomized Participants With PD-L1 Expression Level < 1% | Arm A: Nivo + Ipi | NA | 95% Confidence Interval 41.72 to NA | Months | |
| Overall Survival (OS) - All Randomized Participants With PD-L1 Expression Level < 1% | Arm B: Nivo | NA | 95% Confidence Interval NA to NA | Months | |
| Recurrence-free Survival (RFS) by Baseline Tumor PD-L1 Expression | Arm A: Nivo + Ipi | < 1% Tumor PD-L1 Expression | 33.18 | 95% Confidence Interval 22.21 to NA | Months |
| Recurrence-free Survival (RFS) by Baseline Tumor PD-L1 Expression | Arm B: Nivo | < 1% Tumor PD-L1 Expression | 25.33 | 95% Confidence Interval 19.81 to NA | Months |
| Recurrence-free Survival (RFS) by Baseline Tumor PD-L1 Expression | Arm A: Nivo + Ipi | ≥ 1% Tumor PD-L1 Expression | NA | 95% Confidence Interval NA to NA | Months |
| Recurrence-free Survival (RFS) by Baseline Tumor PD-L1 Expression | Arm B: Nivo | ≥ 1% Tumor PD-L1 Expression | NA | 95% Confidence Interval NA to NA | Months |
| Recurrence-free Survival (RFS) by Baseline Tumor PD-L1 Expression | Arm A: Nivo + Ipi | ≥ 5% Tumor PD-L1 Expression | NA | 95% Confidence Interval NA to NA | Months |
| Recurrence-free Survival (RFS) by Baseline Tumor PD-L1 Expression | Arm B: Nivo | ≥ 5% Tumor PD-L1 Expression | NA | 95% Confidence Interval NA to NA | Months |
| Recurrence-free Survival (RFS) by Baseline Tumor PD-L1 Expression | Arm A: Nivo + Ipi | < 5% Tumor PD-L1 Expression | NA | 95% Confidence Interval 31.18 to NA | Months |
| Recurrence-free Survival (RFS) by Baseline Tumor PD-L1 Expression | Arm B: Nivo | < 5% Tumor PD-L1 Expression | NA | 95% Confidence Interval 27.63 to NA | Months |
| Recurrence-free Survival (RFS) by Baseline Tumor PD-L1 Expression | Arm A: Nivo + Ipi | Non-quantifiable Tumor PD-L1 Expression | NA | 95% Confidence Interval 22.41 to NA | Months |
| Recurrence-free Survival (RFS) by Baseline Tumor PD-L1 Expression | Arm B: Nivo | Non-quantifiable Tumor PD-L1 Expression | NA | 95% Confidence Interval 10.87 to NA | Months |
| Time to Next-Line Therapies - All Randomized Participants | Arm A: Nivo + Ipi | Time to next therapy | NA | 95% Confidence Interval NA to NA | Months |
| Time to Next-Line Therapies - All Randomized Participants | Arm B: Nivo | Time to next therapy | NA | 95% Confidence Interval NA to NA | Months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03068455/results